Warfarin Initiation Protocol for Adults
Start warfarin at 2-5 mg daily (typically 5 mg for most adults, 2-4 mg for elderly ≥60 years), overlap with parenteral anticoagulation (LMWH or UFH) for at least 5 days and until INR is 2.0-3.0 for 2 consecutive days, then adjust dose based on INR response using a standardized algorithm. 1
Initial Dosing Strategy
Starting Dose Selection
- Standard adults (<60 years): 5 mg daily 1
- Elderly (≥60 years): 2-4 mg daily 1
- Patients with liver dysfunction or high bleeding risk: 2-4 mg daily 1
Critical: Do NOT use loading doses >10 mg - they increase bleeding risk without providing faster therapeutic anticoagulation 1
Mandatory Bridging Therapy
You must overlap warfarin with parenteral anticoagulation for acute VTE treatment 2, 3, 2:
- UFH: 80 U/kg IV bolus, then 18 U/kg/hour, adjust by aPTT 2, 3, 2
- Enoxaparin: 1 mg/kg SC every 12 hours OR 1.5 mg/kg once daily 2, 3, 2
- Dalteparin: 200 U/kg SC once daily 2, 3, 2
Continue parenteral anticoagulation for minimum 5 days AND until INR ≥2.0 for 2 consecutive days 2, 1
INR Monitoring Schedule
Week 1
- Day 1: Start warfarin + parenteral anticoagulant
- Day 3-4: Check first INR 4, 5
- Daily INR checks until stable in therapeutic range 1
After Therapeutic INR Achieved
- Check INR every 1-4 weeks once maintenance dose established 1
- More frequent monitoring needed when:
- Starting/stopping other medications
- Dietary changes
- Illness or surgery
Dose Adjustment Algorithm
Target INR: 2.0-3.0 (for most indications including VTE, atrial fibrillation) 2, 3, 2, 1
Adjustment Table
| INR Result | Action |
|---|---|
| <1.5 | Increase weekly dose by 10-20% |
| 1.5-1.9 | Increase weekly dose by 5-10% |
| 2.0-3.0 | No change - therapeutic range |
| 3.1-4.0 | Decrease weekly dose by 5-10% |
| 4.1-5.0 | Hold 0-1 dose, decrease weekly dose by 10-15% |
| 5.1-9.0 | Hold 1-2 doses, give vitamin K 1-2.5 mg PO if bleeding risk, restart at 10-20% lower dose [6] |
| >9.0 | Hold warfarin, give vitamin K 3-5 mg PO, monitor closely [6] |
| >10 with bleeding | Hold warfarin, give vitamin K 10 mg IV slow infusion + fresh frozen plasma or prothrombin complex concentrate [6,7] |
Practical Protocol Example (5 mg Start)
Day 1-3: Warfarin 5 mg daily + parenteral anticoagulant
Day 4: Check INR
- INR <1.5: Continue 5 mg daily
- INR 1.5-1.9: Continue 5 mg daily
- INR 2.0-3.0: Continue 5 mg, recheck INR next day
- INR >3.0: Hold 1 dose, restart at 2.5-3.75 mg
Day 5-7: Continue daily INR checks, adjust as above
Once INR therapeutic × 2 consecutive days: Stop parenteral anticoagulant, continue warfarin at current dose
Expected time to therapeutic INR: 5-7 days on average 1, 4, 5
Alternative Low-Dose Protocol for Elderly
For patients ≥70 years, a 4 mg daily × 3 days protocol is safer 4:
- Give 4 mg daily for 3 days
- Check INR on day 4
- Use day 4 INR to predict maintenance dose (typically 3-4 mg daily)
- This approach has 0% risk of INR >4.0 in elderly patients 4
Common Pitfalls to Avoid
Starting warfarin alone without bridging in acute VTE - warfarin causes transient hypercoagulability in first 3-5 days due to protein C/S depletion before factor II/X depletion 8
Stopping parenteral anticoagulation too early - must wait for INR ≥2.0 × 2 consecutive days, not just one therapeutic INR 2, 1
Using excessive loading doses - doses >10 mg increase bleeding without faster therapeutic effect 1
Inadequate monitoring frequency - daily INR checks needed until stable, then weekly until maintenance dose established 1
Not adjusting for elderly patients - patients ≥60 years need lower starting doses (2-4 mg) due to increased sensitivity 1